![]({"jaw_blog-16_9-small":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/02\/Covid-vaccine-170x95.jpg","width":170},"jaw_blog-16_9-middle":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/02\/Covid-vaccine-270x152.jpg","width":270},"jaw_blog-16_9":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/02\/Covid-vaccine-475x267.jpg","width":475}})
Three Cameroon students injured in fake-vaccine stampede
Three students were injured in Cameroon’s South-West region after a stampede broke out following a rumoured COVID-19 vaccination campaign, The G...
Covid-19 vaccine
![]({"jaw_blog-16_9-small":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/02\/GSK-170x95.jpg","width":170},"jaw_blog-16_9-middle":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/02\/GSK-270x152.jpg","width":270},"jaw_blog-16_9":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/02\/GSK-475x267.jpg","width":475},"jaw_blog-16_9-big":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/02\/GSK-878x494.jpg","width":878},"large":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/02\/GSK-1024x683.jpg","width":1024}})
GSK, Sanofi begin new COVID-19 vaccine trial after setback last year
Britain’s GlaxoSmithKline and France’s Sanofi on Monday said they had started a new clinical trial of their protein-based COVID-19 vaccine candidate a...
![]({"jaw_blog-16_9-small":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/01\/Johnson-Johnson-Covid-19-vaccine-170x95.jpg","width":170},"jaw_blog-16_9-middle":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/01\/Johnson-Johnson-Covid-19-vaccine-270x152.jpg","width":270},"jaw_blog-16_9":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/01\/Johnson-Johnson-Covid-19-vaccine-475x267.jpg","width":475},"jaw_blog-16_9-big":{"file":"https:\/\/bizafricadaily.com\/wp-content\/uploads\/2021\/01\/Johnson-Johnson-Covid-19-vaccine-878x494.jpg","width":878}})
Johnson & Johnson COVID-19 vaccine is 85% effective against severe disease – Company
Johnson & Johnson’s Covid-19 single-shot vaccine was shown to be 66% effective in preventing moderate and severe disease in a global Phase 3...